放大倍数
医学
增生性息肉
结直肠癌
窄带成像
腺瘤
癌症
病理
放射科
核医学
结肠镜检查
内窥镜检查
内科学
计算机视觉
计算机科学
作者
Naohisa Yoshida,Nobuaki Yagi,Yutaka Inada,Munehiro Kugai,Tetsuya Okayama,Kazuhiro Kamada,Kazuhiro Katada,Kazuhiko Uchiyama,Takeshi Ishikawa,Osamu Handa,Tomohisa Takagi,Hideyuki Konishi,Satoshi Kokura,Akio Yanagisawa,Yuji Naito
摘要
Background A new endoscope system with a laser light source, blue laser imaging ( BLI ), has been developed by F ujifilm that allows for narrow‐band light observation. The aim of the present study was to evaluate the utility of BLI for the diagnosis of colorectal polyps. Methods We retrospectively analyzed 314 colorectal polyps that were examined with BLI observation at K yoto P refectural U niversity of M edicine between S eptember 2011 and J anuary 2013. The surface and vascular patterns of polyps detected by published narrow‐band imaging magnification: H iroshima classification were used. Correlations were determined between the classifications and the histopathological diagnoses. Additionally, the ability of BLI without magnification to differentiate between neoplastic or non‐neoplastic polyps was analyzed. Results A total of 41 hyperplastic polyps, 168 adenomas, 80 intramucosal cancer, 11 shallowly invaded submucosal cancer, and 14 deeply invaded submucosal cancer were analyzed.Hyperplastic polyp was observed in 100% of T ype A lesions (39 lesions), adenoma was observed in 89.3% of T ype B lesions (159 lesions), intramucosal cancer and shallowly invaded submucosal cancer was observed in 69.6% of T ype C 1 (92 lesions) and in 84.6% of T ype C 2 (13 lesions), and deeply invaded submucosal cancer was observed in 81.8% of T ype C 3 lesions (11 lesions). The overall diagnostic accuracy of BLI with magnification was 84.3%. Additionally, the diagnostic accuracy of BLI without magnification for differentiating between neoplastic and non‐neoplastic polyps <10 mm in diameter was 95.2%, which was greater than that of white light (83.2%). Conclusion BLI was useful for the diagnosis of colorectal polyps.
科研通智能强力驱动
Strongly Powered by AbleSci AI